# Central Jersey Blood Center, Inc. – FDA Inspection, Mar 12, 2013

Source: https://www.keypedia.com/records/fda_inspections/central-jersey-blood-center-inc/30abfe03-94c1-4e6e-9570-de88ca061831
Source feed: FDA_Inspections

> FDA inspection 822454 of Central Jersey Blood Center, Inc., March 12, 2013. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 822454
- Company Name: Central Jersey Blood Center, Inc.
- Inspection Date: 2013-03-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1003831 - 2017-03-02
- FDA Inspection 904963 - 2014-11-04
- FDA Inspection 733293 - 2011-06-16
- [FDA Inspection 604248 - 2009-07-10](https://www.keypedia.com/records/fda_inspections/central-jersey-blood-center-inc/b9da04df-07d3-4852-b75f-8f6a9824cd7b)

Company: https://www.keypedia.com/companies/central-jersey-blood-center-inc/2013540e-030e-461b-ba7e-b702dc31143f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d